Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
Michael Pfreundschuh(Saarland University), Markus Loeffler(Leipzig University), Eva Lengfelder, Viola Poeschel(Saarland University), Marcel Reiser(Rheinische Hochschule Köln), Frank Hartmann(Saarland University), Martin Hoffmann(Klinikum Ludwigshafen), Leopold Balleisen(Evangelisches Krankenhaus Hamm), Marita Ziepert(Leipzig University of Applied Sciences), Hartmut Eimermacher(St. Marien Hospital), Rüediger Liersch(University Hospital Münster), Anthony D. Ho(Heidelberg University), Rudolf Schmits(Saarland University), Carsten Bokemeyer(Universität Hamburg), Roland Mertelsmann(Unknown), Christina Nickenig(Ludwig-Maximilians-Universität München), Christian Ruebe(Saarland University), Martin Mohren(University Hospital Magdeburg), Michael Clemens(Klinikum Mutterhaus der Borromäerinnen), Bertram Glaß(Helios Hospital Berlin-Buch), Jöerg Schubert(Saarland University), Norma Peter(Carl-Thiem-Klinikum Cottbus), Alfred C. Feller, Norbert Schmitz(University Hospital Münster), Lorenz Trümper(University of Göttingen), Bernd Metzner(Klinikum Oldenburg)
Cited by 1,134
Related Papers
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
|Annals of Internal Medicine|2020|2.4k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k